<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04885010</url>
  </required_header>
  <id_info>
    <org_study_id>PARIS</org_study_id>
    <nct_id>NCT04885010</nct_id>
  </id_info>
  <brief_title>Probiotics and Overreaching Recovery</brief_title>
  <official_title>Probiotics for Athlete's Recovery and Immune System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Padova</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Overloading is a key training principle used by athletes and coaches to improve physical&#xD;
      performance. Intensified training periods are therefore commonly incorporated into the course&#xD;
      of a regular training season. From a clinical point of view, very intense periods of training&#xD;
      are associated with a temporary immunological deficiency which can lead to teh &quot;overreaching&#xD;
      syndroms&quot;.&#xD;
&#xD;
      During periods of overreaching, nutritional strategies are mainly aimed at ensuring&#xD;
      sufficient amounts of energy to support the increase in effort. However less is known about&#xD;
      nutritional supplements to attenuated the inflammatory/immunological response to training&#xD;
      stress.&#xD;
&#xD;
      Probiotic bacteria are defined as live food ingredients beneficial to the host's health.&#xD;
      Numerous health benefits have been attributed to probiotics, including effects on&#xD;
      gastrointestinal tract function and disease, immune function, hyperlipidemia, hypertension,&#xD;
      and allergic conditions. Studies in the literature on the ergogenic effect of probiotics in&#xD;
      athletes are still scarce today. this study aims to explore the potential role of probiotics&#xD;
      on performance, recovery from fatigue and immune function during intensive period of&#xD;
      training.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>lymphocyte subpopulation total T (CD3+)</measure>
    <time_frame>Change from baseline to up to 15 days</time_frame>
    <description>lymphocyte subpopulation: total T (CD3+) %</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T-helper (CD4+)</measure>
    <time_frame>Change from baseline to up to 15 days</time_frame>
    <description>lymphocyte subpopulation: T-helper (CD4+) %</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T-suppressor (CD8+)</measure>
    <time_frame>Change from baseline to up to 15 days</time_frame>
    <description>lymphocyte subpopulation: T-suppressor (CD8+) %</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Fatigue; Muscle, Heart</condition>
  <condition>Immunosuppression</condition>
  <arm_group>
    <arm_group_label>Probiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants will train for 15 days while consuming the dietary supplement. During the last 8 days the intensity of training will increase to induce overreaching.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>participants will train for 15 days while consuming the dietary supplement. During the last 8 days the intensity of training will increase to induce overreaching.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>probiotics</intervention_name>
    <description>participants will be given probiotics twice a day for 15 days</description>
    <arm_group_label>Probiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>participants will be given a placebo twice a day for 15 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 25-55 years&#xD;
&#xD;
          -  Body mass index:&gt; 18 and &lt;30 kg / m2&#xD;
&#xD;
          -  Stable body weight for at least 3 months&#xD;
&#xD;
          -  regular practice of physical activity for at least 2 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic diseases (cardiovascular, hepatic, respiratory, cancer)&#xD;
&#xD;
          -  Acute inflammatory states, infections or other pathologies&#xD;
&#xD;
          -  Regular use of probiotics&#xD;
&#xD;
          -  Use or treatment with steroids (within the previous 3 months)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tatiana Moro, PhD</last_name>
    <phone>0498275306</phone>
    <email>tatiana.moro@unipd.it</email>
  </overall_contact>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 7, 2021</study_first_submitted>
  <study_first_submitted_qc>May 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>May 7, 2021</last_update_submitted>
  <last_update_submitted_qc>May 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

